Finalgon ointment 20 gr - Anesthesia

FINALGON®

 

Manual for medical use of the drug

 

The composition of the drug:

 

active substance: vanland nonlove acid, nicotinic acid beta-bookshelve ether;

 

1 g ointment contains vanlede acid nonlove 4.0 mg and nicotinic acid beta-butoxyl ether 25.0 mg;

 

excipients: isopropylacetate, silica colloidal anhydrous, white soft paraffin, sorbic acid, citronella Ceylon, purified water.

 

Dosage form. Ointment.

 

Almost colourless or brownish, translucent or almost transparent, soft, homogeneous ointment with the smell of lemon oil.

 

The name and location of manufacturer. Haupt Pharma Wolfratshausen GmbH, Germany. Pfaffenrieder Str.5, D-82515 Wolfratshausen, Germany.

 

or GLOBOPHARM Farmaceutske of Productos - und khandel'sgezel'shaft mbH, Austria.

 

Breitenfurter Strasse 251 A-1231 Wien, Austria.

 

Pharmacotherapeutic group. Means, used locally at the joint and muscle pain. ATC code M 02A X 10.

 

Vanland acid nonlove is a synthetic analogue of capsaicin with analgesic properties, the repeated external application of which leads to inhibition of substance P in peripheral pain C-fibers and A-Delta nerve fibers.

 

Nicotinic acid beta-butoxyl ether. Niacin is a b vitamin that has vasodilating properties that are mediated by prostaglandins.

 

The combination vanlede nonlove acid and nicotinic acid beta-butoxyl ether is complementary vasodilator properties, which reduce the time is redness of the skin when applying.

 

FINALGON applied externally, the clinical effect was manifested at the site of application of ointment. Since the reaction (erythema and increased skin temperature) occurs a few minutes after application, it is obvious the rapid penetration of active ingredients through the skin.

 

Indications for use. Arthritis, rheumatic pain in joints and muscles due to strain; lumbago, neuritis, sciatica, bursitis and tendovaginitis; both locally an irritant agent for peripheral circulatory disorders.

 

Contraindications. FINALGON contraindicated in children, patients with hypersensitivity to the drug or with very sensitive skin.

 

FINALGON should not be applied to wounds, inflamed and damaged skin, mucous membranes and skin diseases.

 

Special warnings. It is assumed a minor degree of redness and perhaps a light fleeting sensations of itching or burning sensation at the application site. This may be partly caused by the use of excessive amounts Nalgona. After using Finalgon you need to thoroughly wash hands. Avoid accidental contact of the ointment to other areas of the body except the painful areas that need treatment.

 

Patients with sensitive skin should not take a hot bath or shower before or after applying Finalgon.

 

Use during pregnancy or breast-feeding. Through the lack of information on the use of Nalgona not recommended during pregnancy and lactation. Unknown, penetrates FINALGON to breast milk.

 

The ability to influence the rate of reaction at management of motor transport or operating other mechanisms. Data are not available.

 

Children. The drug is not administered to children.

 

Method of application and doses. Application Finalgon should start with a very small dose. Aluminum membrane must be completely pierced with the pointed end caps that must be screwed up. Not more than 1/2 cm of ointment (a pea size) on an area the size of the palm of the hand, required no effort to put on the painful area, applying the applicator that is attached. The therapeutic effect of applying Finalgon may increase if you cover treated skin area with a woolen cloth.

 

It is recommended to apply 2-3 times a day until symptoms disappear.

 

Duration of application depends on the nature of the disease and the effectiveness of therapy being done.

 

Overdose. When applying excessive amounts Nalgona the intensity of hyperemia, itching and burning, can reduce the lubrication of skin with oil (e.g. sunflower) or nourishing cream.

 

Side effects. Possible allergic reactions such as rash, hives, swelling of the face.

 

Interaction with other medicinal products. Interaction with other drugs, applied topically or systemically, is not known.

 

The expiration date. 4 years, do not use after the expiry date stated on the package!

 

The storage conditions. Keep at temperature not exceeding 30 ºc. Keep out of reach of children!

 

Packing. 20 g in an aluminum tube; 1 tube complete with applicator in a cardboard box.